SUZZI, FABRIZIA
 Distribuzione geografica
Continente #
AS - Asia 485
EU - Europa 234
NA - Nord America 162
AF - Africa 25
SA - Sud America 25
Totale 931
Nazione #
CN - Cina 199
US - Stati Uniti d'America 157
SG - Singapore 143
IT - Italia 126
KR - Corea 49
NL - Olanda 34
HK - Hong Kong 30
BR - Brasile 22
DE - Germania 17
IN - India 17
VN - Vietnam 16
JP - Giappone 13
FR - Francia 11
CI - Costa d'Avorio 9
FI - Finlandia 8
GB - Regno Unito 8
SE - Svezia 8
SC - Seychelles 7
DZ - Algeria 5
ID - Indonesia 5
PK - Pakistan 5
RU - Federazione Russa 5
CH - Svizzera 4
IE - Irlanda 4
TG - Togo 3
AR - Argentina 2
AT - Austria 2
BG - Bulgaria 2
CA - Canada 2
CZ - Repubblica Ceca 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MX - Messico 2
CR - Costa Rica 1
EC - Ecuador 1
ES - Italia 1
MY - Malesia 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
Totale 931
Città #
Hefei 112
Singapore 104
Bologna 54
Seoul 49
Ashburn 43
Hong Kong 29
Boardman 15
Milan 14
Beijing 12
Santa Clara 12
Bengaluru 10
Abidjan 9
Tokyo 8
Ho Chi Minh City 7
Chandler 6
Florence 6
Chicago 5
Lahore 5
Los Angeles 5
New York 5
Ōtsu 5
Amsterdam 4
Dublin 4
Düsseldorf 4
Helsinki 4
Jakarta 4
Lissone 4
Redondo Beach 4
São Paulo 4
Tongling 4
Verona 4
Bern 3
Brooklyn 3
Council Bluffs 3
Dallas 3
Forlì 3
Frankfurt am Main 3
Jinan 3
Lappeenranta 3
Lomé 3
Pune 3
Almaty 2
Amman 2
Bacoli 2
Brno 2
Chongqing 2
Da Nang 2
Ferrara 2
Hanoi 2
Holon 2
Lauterbourg 2
London 2
Modena 2
Monza 2
Naples 2
Ningbo 2
Orem 2
Padova 2
Parma 2
Plainfield 2
Porto Alegre 2
Portsmouth 2
Quận Một 2
Rimini 2
Rome 2
San Clemente 2
San Lazzaro di Savena 2
Seattle 2
Sofia 2
Turin 2
Varese 2
Xi'an 2
Abeokuta 1
Alajuela 1
Ankara 1
Araras 1
Bolzano 1
Bremen 1
Buenos Aires 1
Buffalo 1
Bühl 1
Campinas 1
Canoas 1
Casalecchio di Reno 1
Catanduva 1
Changchun 1
Chennai 1
City of London 1
Crespellano 1
Denver 1
Desterro 1
Donetsk 1
Extrema 1
Fairfield 1
Falkenstein 1
Fortaleza 1
Guadalajara 1
Guayaquil 1
Houston 1
Hoàng Mai 1
Totale 675
Nome #
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 197
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 160
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 154
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 137
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies 120
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC 105
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 80
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 3
Totale 956
Categoria #
all - tutte 2.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 0 0 0 0 9 1 2 10 1
2022/202379 0 6 15 5 5 9 5 7 13 0 9 5
2023/202447 2 1 0 7 1 11 2 4 5 9 0 5
2024/2025358 18 19 17 14 14 7 29 11 19 61 49 100
2025/2026449 95 118 80 70 61 25 0 0 0 0 0 0
Totale 956